Symon Cotton has been reflecting on the future of the genomics ecosystem. Here he discusses how genomics – plus the emergence of panomics and long read sequencing – could inform clinical practice and patient care ...

The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this ...

Lizzie Thomas presents her case for designing improved, sustainable drug delivery product design. Currently, the approach is dominated at the outset by patient-centricity. This focus means that wider, more long-term implications simply aren’t considered early enough ...

Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. This biomarker that is used to screen and sort live cells for cell therapies ...

グローバル製薬企業は成功と失敗の大きな分かれ道に差し掛かっています。このような状況下では、業界が一丸となって新技術のもたらす一世一代のチャンスを掴むことが欠かせません。

Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...

AI-based methods are offering superhuman image enhancement. But their medical applications are not without risk – unless, that is, you consider a hybrid approach… ...

Decarbonising aviation is a herculean task, but the HBx organism holds the potential to radically change both the carbon intensity of transport fuels and the economics of the biofuel industry ...

This whitepaper describes the benefits of introducing advanced wireless capabilities into surgical and critical care settings, the technical approaches to achieve this, and the challenges that can arise. It concludes with our vision for some exemplar use cases.  ...